Centrally administered tuberoinfundibular peptide of 39 residues inhibits arginine vasopressin release in conscious rats

Endocrinology

Volumn 144, Issue 7, 2003, Pages 2791-2796

  Sugimura, Yoshihisa ^a   Murase, Takashi ^b   Ishizaki, Seiji ^a   Tachikawa, Kazushige ^a   Arima, Hiroshi ^a   Miura, Yoshitaka ^a   Usdin, Ted B ^c   Oiso, Yutaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; MACROGOL; NALOXONE; OPIATE RECEPTOR; PARATHYROID HORMONE RECEPTOR; PEPTIDE; PROTEIN TIP39; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEHYDRATION; HORMONE RELEASE; HYPEROSMOLALITY; HYPOTHALAMUS; MALE; NEUROENDOCRINOLOGY; NONHUMAN; OSMOREGULATION; PRESSORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; TUBEROHYPOPHYSEAL TRACT;

ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; CONSCIOUSNESS; DEHYDRATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOVOLEMIA; INJECTIONS, INTRAVENTRICULAR; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; WATER-ELECTROLYTE BALANCE;

EID: 0038336902     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-0017     Document Type: Article

References (35)

1. Usdin TB, Hoare SR, Wang T, Mezey E, Kowalak JA 1999 TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus. Nat Neurosci 2:941-943
2. Usdin TB, Gruber C, Bonner TI 1995 Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 270:15455-15458
3. Juppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski Jr LF, Hock J, Potts Jr JT, Kronenberg HM, Segre GE 1991 A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254:1024-1026
4. Hoare SR, Usdin TB 2001 Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors. Curr Pharm Des 7:689-713
5. Rubin DA, Juppner H 1999 Zebrafish express the common parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R) and a novel receptor (PTH3R) that is preferentially activated by mammalian and fugufish parathyroid hormone-related peptide. J Biol Chem 274:28185-28190
6. Usdin TB, Hilton J, Vertesi T, Harta G, Segre G, Mezey E 1999 Distribution of the parathyroid hormone 2 receptor in rat: immunolocalization reveals expression by several endocrine cells. Endocrinology 140:3363-3371
7. Wang T, Palkovits M, Rusnak M, Mezey E, Usdin TB 2000 Distribution of parathyroid hormone-2 receptor-like immunoreactivity and messenger RNA in the rat nervous system. Neuroscience 100:629-649
8. Usdin TB, Bonner TI, Harta G, Mezey E 1996 Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. Endocrinology 137:4285-4297
9. Usdin TB 1997 Evidence for a parathyroid hormone-2 receptor selective ligand in the hypothalamus. Endocrinology 138:831-834
10. Hoare SR, Bonnet TI, Usdin TB 1999 Comparison of rat and human parathyroid hormone 2 (PTH2) receptor activation: PTH is a low potency partial agonist at the rat PTH2 receptor. Endocrinology 140:4419-4425
11. Ward HL, Small CJ, Murphy KG, Kennedy AR, Ghatei MA, Bloom SR 2001 The actions of tuberoinfundibular peptlde on the hypothalamo-pituitary axes. Endocrinology 142:3451-3456
12. Dobolyi A, Ueda H, Uchida H, Palkovits M, Usdin TB 2002 Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception. Proc Natl Acad Sci USA 99:1651-1656
13. Eichinger A, Fiaschi-Taesch N, Massfelder T, Fritsch S, Barthelmebs M, Helwig JJ 2002 Transcript expression of the tuberoinfundibular peptide (TIP)39/PTH2 receptor system and non-PTH1 receptor-mediated tonic effects of TIP39 and other PTH2 receptor ligands in renal vessels. Endocrinology 143:3036-3043
14. Bisset GW, Chowdrey HS 1988 Control of release of vasopressin by neuroendocrine reflexes. Q J Exp Physiol 73:811-872
15. Robertson GL 1976 The regulation of vasopressin function in health and disease. Recent Prog Horm Res 33:333-385
16. Baker RA, Herkenham M 1995 Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J Comp Neurol 358:518-530
17. Bell ME, Bhatnagar S, Akana SF, Choi S, Dallman MF 2000 Disruption of arcuate/paraventricular nucleus connections changes body energy balance and response to acute stress. J Neurosci 20:6707-6713
18. Kawano H, Masuko S 2000 β-Endorphin-, adrenocorticotrophic hormone-, and neuropeptide Y-containing projection fibers from the arcuate hypothalamic nucleus make synaptic contacts on to nucleus preopticus medianus neurons projecting to the paraventricular hypothalamic nucleus in the rat. Neuroscience 98:555-565
19. Haaf JA, Maigret C, Andringa-Bakker EA, van Wimersma Greidanus TB 1987 Dynorphin-(1-13) is a potent in vivo suppressor of vasopressin levels in the rat. Acta Endocrinol (Copenh) 114:96-101
20. Summy-Long JY, Rosella-Dampman LM, McLemore GL, Koehler E 1990 κ-Opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration. Neuroendocrinology 51:376-384
21. Van de Heijning BJ, Koekkoek-Van den Herik I, Van Wimersma Greidanus TB 1991 The opioid receptor subtypes μ and κ, but not δ, are involved in the control of the vasopressin and oxytocin release in the rat. Eur J Pharmacol 209:199-206
22. Van de Heijning BJ, Koekkoek-Van den Herik I, Maigret C, Van Wimersma Greidanus TB 1991 Pharmacological assessment of the site of action of opioids on the release of vasopressin and oxytocin in the rat. Eur J Pharmacol 197:175-180
23. Yamamoto S, Morimoto I, Yanagihara N, Zeki K, Fujihira T, Izumi F, Yamashita H, Eto S 1997 Parathyroid hormone-related peptide-(1-34) [PTHrP-(1-34)] induces vasopressin release from the rat supraoptic nucleus in vitro through a novel receptor distinct from a type I or type II PTH/PTHrP receptor. Endocrinology 138:2066-2072
24. Yamamoto S, Morimoto I, Zeki K, Ueta Y, Yamashita H, Kannan H, Eto S 1998 Centrally administered parathyroid hormone (PTH)-related protein(1-34) but not PTH(1-34) stimulates arginine-vasopressin secretion and its messenger ribonucleic acid expression in supraoptic nucleus of the conscious rats. Endocrinology 139:383-388
25. Ishizaki S, Murase T, Sugimura Y, Kakiya S, Yokoi H, Tachikawa K, Arima H, Miura Y, Oiso Y 2002 Role of ghrelin in the regulation of vasopressin release in conscious rats. Endocrinology 143:1589-1593
26. Dunn FL, Brennan TJ, Nelson AE, Robertson GL 1973 The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J Clin Invest 52:3212-3219
27. Kakiya S, Murase T, Arima H, Yokoi H, Iwasaki Y, Miura Y, Oiso Y 2000 Role of endogenous nociceptin in the regulation of arginine vasopressin release in conscious rats. Endocrinology 141:4466-4471
28. Oiso Y, Iwasaki Y, Kondo K, Takatsuki K, Tomita A 1988 Effect of the opioid κ-receptor agonist U50488H on the secretion of arginine vasopressin. Study on the mechanism of U50488H-induced diuresis. Neuroendocrinology 48:658-662
29. Doi N, Brown CH, Cohen HD, Leng G, Russell JA 2001 Effects of the endogenous opioid peptide, endomorphin 1, on supraoptic nucleus oxytocin and vasopressin neurones in vivo and in vitro. Br J Pharmacol 132:1136-1144
30. Hoare SR, Clark JA, Usdin TB 2000 Molecular determinants of tuberoinfundibular peptide of 39 residues (TIP39) selectivity for the parathyroid hormone-2 (PTH2) receptor. N-terminal truncation of TIP39 reverses PTH2 receptor/PTH1 receptor binding selectivity. J Biol Chem 275:27274-27283
31. Feldberg W 1976 The ventral surface of the brain stem: a scarcely explored region of pharmacological sensitivity. Neuroscience 1:427-441
32. Usdin TB 2000 The PTH2 receptor and TIP39: a new peptide-receptor system. Trends Pharmacol Sci 21:128-130
33. Lantos TA, Gorcs TJ, Palkovits M 1995 Immunohistochemical mapping of neuropeptides in the premamillary region of the hypothalamus in rats. Brain Res Brain Res Rev 20:209-249
34. Berkowitz BA, Ngai SH, Hempstead J, Spector S 1975 Disposition of naloxone: use of a new radioimmunoassay. J Pharmacol Exp Ther 195:499-504
35. Arima H, Murase T, Kondo K, Iwasaki Y, Oiso Y 1996 Centrally administered neuropeptide FF inhibits arginine vasopressin release in conscious rats. Endocrinology 137:1523-1529